FI56676C - Foerfarande foer framstaellning av nya amidderivat av nonapeptid som befraemjar loesgoerandet av aeggceller - Google Patents

Foerfarande foer framstaellning av nya amidderivat av nonapeptid som befraemjar loesgoerandet av aeggceller Download PDF

Info

Publication number
FI56676C
FI56676C FI1375/73A FI137573A FI56676C FI 56676 C FI56676 C FI 56676C FI 1375/73 A FI1375/73 A FI 1375/73A FI 137573 A FI137573 A FI 137573A FI 56676 C FI56676 C FI 56676C
Authority
FI
Finland
Prior art keywords
parts
weight
pro
dissolved
gly
Prior art date
Application number
FI1375/73A
Other languages
English (en)
Finnish (fi)
Other versions
FI56676B (fi
Inventor
Masahiko Fujino
Shigeru Kobayashi
Mikihiko Obayashi
Susumu Shinagawa
Tsunehiko Fukuda
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP4268672A external-priority patent/JPS5324423B2/ja
Priority claimed from JP11845272A external-priority patent/JPS5324424B2/ja
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Publication of FI56676B publication Critical patent/FI56676B/fi
Application granted granted Critical
Publication of FI56676C publication Critical patent/FI56676C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides
FI1375/73A 1972-04-29 1973-04-27 Foerfarande foer framstaellning av nya amidderivat av nonapeptid som befraemjar loesgoerandet av aeggceller FI56676C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP4268672 1972-04-29
JP4268672A JPS5324423B2 (de) 1972-04-29 1972-04-29
JP11845272A JPS5324424B2 (de) 1972-11-24 1972-11-24
JP11845272 1972-11-24

Publications (2)

Publication Number Publication Date
FI56676B FI56676B (fi) 1979-11-30
FI56676C true FI56676C (fi) 1980-03-10

Family

ID=26382407

Family Applications (1)

Application Number Title Priority Date Filing Date
FI1375/73A FI56676C (fi) 1972-04-29 1973-04-27 Foerfarande foer framstaellning av nya amidderivat av nonapeptid som befraemjar loesgoerandet av aeggceller

Country Status (17)

Country Link
US (1) US3853837A (de)
AT (1) AT333988B (de)
AU (1) AU453931B2 (de)
CA (1) CA1005815A (de)
CH (1) CH580065A5 (de)
CS (1) CS188162B2 (de)
DE (2) DE2321174C2 (de)
DK (1) DK147851C (de)
ES (1) ES414197A1 (de)
FI (1) FI56676C (de)
FR (1) FR2183021B1 (de)
GB (1) GB1403642A (de)
HU (1) HU168696B (de)
NL (2) NL176856C (de)
NO (1) NO139560C (de)
PL (1) PL95790B1 (de)
SE (1) SE397520B (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3931138A (en) * 1973-03-13 1976-01-06 Abbott Laboratories N-carbobenzoxy-pyroglutamyl-histidine
AT347054B (de) * 1973-09-29 1978-12-11 Takeda Chemical Industries Ltd Verfahren zur herstellung von neuen nonapeptidamid-derivaten
GB1532211A (en) * 1974-10-25 1978-11-15 Wellcome Found Lh-rh peptide analogues
US4338305A (en) * 1975-03-24 1982-07-06 American Home Products Corporation Use of LRH and LRH agonists
AU497512B2 (en) * 1975-04-15 1978-12-14 Ici Australia Limited Nona and deca-peptides
US4034082A (en) * 1976-03-01 1977-07-05 Abbott Laboratories Method to prevent reproduction in warm-blooded female animals with nonapeptides
DE2905502C2 (de) * 1979-02-14 1982-07-15 Hoechst Ag, 6000 Frankfurt Verfahren zur Herstellung von LH-RH bzw. LH-RH-Analoga und Pyroglutamyl-N↑i↑m↑-dinitrophenyl-histidin
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4675189A (en) * 1980-11-18 1987-06-23 Syntex (U.S.A.) Inc. Microencapsulation of water soluble active polypeptides
US4659696A (en) * 1982-04-30 1987-04-21 Takeda Chemical Industries, Ltd. Pharmaceutical composition and its nasal or vaginal use
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5068221A (en) * 1989-05-09 1991-11-26 Mathias John R Treatment of motility disorders with a gnrh analog
JP2653255B2 (ja) 1990-02-13 1997-09-17 武田薬品工業株式会社 長期徐放型マイクロカプセル
CA2050425A1 (en) 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
NO302481B1 (no) 1990-10-16 1998-03-09 Takeda Chemical Industries Ltd Polymer for et preparat med forlenget frigjöring, samt preparat med forlenget frigjöring
US5434136A (en) * 1990-12-14 1995-07-18 Mathias; John R. Treatment of motility disorders with a GNRH analog
US5518730A (en) * 1992-06-03 1996-05-21 Fuisz Technologies Ltd. Biodegradable controlled release flash flow melt-spun delivery system
DE69316101T2 (de) 1992-08-07 1998-10-22 Takeda Chemical Industries Ltd Herstellung von Mikrokapseln, die wasserlösliche Arzneimittel enthalten
US5594091A (en) * 1994-02-21 1997-01-14 Takeda Chemical Industries, Ltd. Matrix for sustained-release preparation
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
US5837281A (en) 1995-03-17 1998-11-17 Takeda Chemical Industries, Ltd. Stabilized interface for iontophoresis
US7833543B2 (en) * 1995-06-07 2010-11-16 Durect Corporation High viscosity liquid controlled delivery system and medical or surgical device
US6413536B1 (en) 1995-06-07 2002-07-02 Southern Biosystems, Inc. High viscosity liquid controlled delivery system and medical or surgical device
CA2192773C (en) 1995-12-15 2008-09-23 Hiroaki Okada Production of sustained-release preparation for injection
CA2192782C (en) 1995-12-15 2008-10-14 Nobuyuki Takechi Production of microspheres
CN1095681C (zh) * 1996-06-20 2002-12-11 久光制药株式会社 一种用于离子电渗疗法的装置结构
US20060025328A1 (en) * 1997-05-28 2006-02-02 Burns Patrick J Compositions suitable for controlled release of the hormone GnRH and its analogs
US6051558A (en) * 1997-05-28 2000-04-18 Southern Biosystems, Inc. Compositions suitable for controlled release of the hormone GnRH and its analogs
EP0882736A1 (de) * 1997-06-02 1998-12-09 Laboratoire Theramex S.A. Peptidanaloge des LH-RH, ihre Verwendungen und die sie enthaltenden pharmazeutischen Zusammensetzungen
JP4414517B2 (ja) 1999-09-01 2010-02-10 久光製薬株式会社 イオントフォレーシス用デバイス構造体
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
SI2218448T1 (sl) 2002-12-13 2016-01-29 Durect Corporation Sistem za oralno dajanje zdravila, ki obsega tekoči nosilec materialov z visoko viskoznostjo
KR101351771B1 (ko) 2004-09-17 2014-02-17 듀렉트 코퍼레이션 바람직하게 ｓａｉｂ와 같은 당 에스테르를 포함하는지속적인 국소 마취제 조성물
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
PT2117521E (pt) 2006-11-03 2012-09-10 Durect Corp Sistemas de administração transdérmica que compreendem bupivacaína
AU2008347158B8 (en) 2007-12-06 2013-08-22 Durect Corporation Oral pharmaceutical dosage forms
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
EP2983468A4 (de) 2013-03-15 2016-09-07 Durect Corp Zusammensetzungen mit rheologiemodifikator zur reduzierung der auflösungsvariabilität
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods

Also Published As

Publication number Publication date
DE2321174A1 (de) 1973-11-08
CA1005815A (en) 1977-02-22
DK147851C (da) 1986-03-10
PL95790B1 (pl) 1977-11-30
NO139560C (no) 1979-04-04
NL930004I1 (nl) 1993-04-01
ES414197A1 (es) 1976-05-01
ATA377173A (de) 1976-04-15
SE397520B (sv) 1977-11-07
DK147851B (da) 1984-12-24
FI56676B (fi) 1979-11-30
NL176856C (nl) 1985-06-17
CH580065A5 (de) 1976-09-30
GB1403642A (en) 1975-08-28
AT333988B (de) 1976-12-27
FR2183021A1 (de) 1973-12-14
NO139560B (no) 1978-12-27
NL7305995A (de) 1973-10-31
AU5467673A (en) 1974-10-17
DE2366379C2 (de) 1985-01-17
US3853837A (en) 1974-12-10
CS188162B2 (en) 1979-02-28
DE2321174C2 (de) 1982-04-15
HU168696B (de) 1976-06-28
FR2183021B1 (de) 1976-04-09
AU453931B2 (en) 1974-10-17

Similar Documents

Publication Publication Date Title
FI56676C (fi) Foerfarande foer framstaellning av nya amidderivat av nonapeptid som befraemjar loesgoerandet av aeggceller
FI60553B (fi) Foerfarande foer framstaellning av ovulationsframkallande nonapeptidamidderivat
US4008209A (en) Nonapeptide amide analogs of luteinizing releasing hormone
FI71567C (fi) Foerfarande foer framstaellning av gonadoliberinderivat.
JPH0314599A (ja) ペプチド誘導体類
CS199673B2 (en) Method of producing polypeptides
HU185920B (en) Process for producing new polypeptides
DK149862B (da) Analogifremgangsmaade til fremstilling af lh-rh-analoge dekapeptidamider eller et salt eller et metalkompleks deraf
DK148905B (da) Analogifremgangsmaade til fremstilling af lh-rh-analoge nonapeptidderivater
US6235876B1 (en) Liquid phase process for the preparation of GNRH peptides
US4490364A (en) CCK Agonists II
EP0082568B1 (de) Retro-inverso Analoga von C-terminalen Penta- und Hexapeptiden der Verbindung P
JPS6340199B2 (de)
US4638046A (en) Retro-inverso C-terminal hexapeptide analogues of substance P
Izeboud et al. Synthesis of substance P via its sulfoxide by the repetitive excess mixed anhydride (REMA) method
US3862927A (en) Process for preparation of vasoactive intestinal peptide
FI85866B (fi) Foerfarande foer framstaellning av nya gonadoliberinderivat vilka foermaor frigoera luteniserande eller follikelstimulerande hormon.
Bodanszky et al. 8-L-citrulline vasopressin and 8-L-citrulline oxytocin
Van Nispen et al. INVESTIGATION OF THE ROLE OF TRYPTOPHAN IN α‐MSH*: Replacement by L‐Pentamethylphenylalanine and L‐Phenylalanine
US4001199A (en) Novel polypeptides useful for treating diabetes and hypercholesteremia
Thierry et al. Synthesis and activity of NAcSerAspLysPro analogs on cellular interactions between T-cell and erythrocytes in rosette formation
US3801561A (en) Derivatives of salmon thyrocalcitonin
EP0227410A2 (de) Peptid-Derivate, deren Herstellung und Verwendung
US4018754A (en) Novel polypeptides having ACTH-like action
US4018753A (en) Polypeptides with ACTH-like activities